Escalon Medical Corp. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported revenue was USD 2.87 million compared to USD 3.01 million a year ago. Net loss was USD 0.076321 million compared to USD 0.006043 million a year ago. Basic loss per share from continuing operations was USD 0.01. Diluted loss per share from continuing operations was USD 0.01.
For the six months, revenue was USD 5.81 million compared to USD 5.61 million a year ago. Net loss was USD 0.097518 million compared to USD 0.326767 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago.